AbbVie (BSP:ABBV34) Current Accrued Expense : R$118,472 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AbbVie Current Accrued Expense?

AbbVie's Current Accrued Expense for the quarter that ended in Dec. 2023 was R$118,472 Mil.

AbbVie's quarterly Current Accrued Expense increased from Jun. 2023 (R$131,225 Mil) to Sep. 2023 (R$146,472 Mil) but then declined from Sep. 2023 (R$146,472 Mil) to Dec. 2023 (R$118,472 Mil).

AbbVie's annual Current Accrued Expense increased from Dec. 2021 (R$97,683 Mil) to Dec. 2022 (R$103,796 Mil) and increased from Dec. 2022 (R$103,796 Mil) to Dec. 2023 (R$118,472 Mil).

AbbVie Current Accrued Expense Historical Data

The historical data trend for AbbVie's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Current Accrued Expense Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

35,335.64

79,989.80

97,682.74

103,795.98

118,472.26

AbbVie Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															129,115.99	131,224.63	146,471.97	118,472.26	-

AbbVie Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

AbbVie Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of AbbVie's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (BSP:ABBV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV:Austria

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines